The US Food and Drug Administration has also started to recognize the potential of these drugs: in 2018, they designated certain psychedelic treatments with a “breakthrough therapy” status, which means that it has therapeutic potential. Several renowned medical schools and hospitals around the United States have also opened psychedelic medicine departments which have been entirely devoted to studying the impact of psilocybin and LSD.
Try Cornbread Hemp's new USDA-certified organic THC gummy. It's the first hemp THC gummy of…
Register to vote today to make your voice heard. The post Cannabis voter guide to…
We've all heard it before: smoke weed, and you'll become a lazy, unmotivated bum. The…
New THC+CBC Mood Mints from Rare Cannabinoid Company bring on mood-boosting effects quickly thanks to…
Pioneering research from Columbia University in New York suggests that psilocybin, the key component in…
A groundbreaking new study, funded by the Centers for Disease Control and Prevention, suggests exactly…